P913-0129 Screening compound: 1-(4-FLUOROPHENYL)-4-[5-(2-PYRIDYL)-1,2,4-OXADIAZOL-3-YL]-2-PYRROLIDINONE

P913-0129 Screening compound: 1-(4-FLUOROPHENYL)-4-[5-(2-PYRIDYL)-1,2,4-OXADIAZOL-3-YL]-2-PYRROLIDINONE
P913-0129 Screening compound: 1-(4-FLUOROPHENYL)-4-[5-(2-PYRIDYL)-1,2,4-OXADIAZOL-3-YL]-2-PYRROLIDINONE alternative view

Chemical Structure Depiction of ChemDiv screening compound P913-0129
1-(4-FLUOROPHENYL)-4-[5-(2-PYRIDYL)-1,2,4-OXADIAZOL-3-YL]-2-PYRROLIDINONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P913-0129

Molecular Formula

C17H13FN4O2 (C17 H13 FN4 O2)

Compound Name

1-(4-FLUOROPHENYL)-4-[5-(2-PYRIDYL)-1,2,4-OXADIAZOL-3-YL]-2-PYRROLIDINONE

IUPAC name

n/a

SMILES

O=C(CC(C1)c2noc(-c3ncccc3)n2)N1c(cc1)ccc1F

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

324.31

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.333

Distribution Coefficient, logD

2.333

Water Solubility, LogSw

-2.61

Polar Surface Area

57.442

Acid Dissociation Constant (pKa)

11.87

Base Dissociation Constant (pKb)

3.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

17.60

P913-0129 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P913-0129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P913-0129?
Check Price and Availability of P913-0129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P913-0129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P913-0129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P913-0129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P913-0129 available by request